Smith GN - Search Results

1

Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management.

Magee LA, Smith GN, Bloch C, Côté AM, Jain V, Nerenberg K, von Dadelszen P, Helewa M, Rey E. Magee LA, et al. Among authors: smith gn. J Obstet Gynaecol Can. 2022 May;44(5):547-571.e1. doi: 10.1016/j.jogc.2022.03.002. J Obstet Gynaecol Can. 2022. PMID: 35577426 Review.

2

Hypertensive disorders of pregnancy and long-term risk of hypertension: what do Ontario prenatal care providers know, and what do they communicate?

MacDonald SE, Walker M, Ramshaw H, Godwin M, Chen XK, Smith G. MacDonald SE, et al. J Obstet Gynaecol Can. 2007 Sep;29(9):705-10. doi: 10.1016/s1701-2163(16)32601-9. J Obstet Gynaecol Can. 2007. PMID: 17825134

3

Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes.

Menzies J, Magee LA, Macnab YC, Ansermino JM, Li J, Douglas MJ, Gruslin A, Kyle P, Lee SK, Moore MP, Moutquin JM, Smith GN, Walker JJ, Walley KR, Russell JA, von Dadelszen P. Menzies J, et al. Among authors: smith gn. Hypertens Pregnancy. 2007;26(4):447-62. doi: 10.1080/10641950701521742. Hypertens Pregnancy. 2007. PMID: 18066963 Free article.

4

RETIRED: Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy.

Magee LA, Helewa M, Rey E; HYPERTENSION GUIDELINE COMMITTEE; STRATEGIC TRAINING INITIATIVE IN RESEARCH IN THE REPRODUCTIVE HEALTH SCIENCES (STIRRHS) SCHOLARS. Magee LA, et al. J Obstet Gynaecol Can. 2008 Mar;30(3 Suppl):S1-S2. doi: 10.1016/S1701-2163(16)32776-1. J Obstet Gynaecol Can. 2008. PMID: 18817592

5

An international trial of antioxidants in the prevention of preeclampsia (INTAPP).

Xu H, Perez-Cuevas R, Xiong X, Reyes H, Roy C, Julien P, Smith G, von Dadelszen P, Leduc L, Audibert F, Moutquin JM, Piedboeuf B, Shatenstein B, Parra-Cabrera S, Choquette P, Winsor S, Wood S, Benjamin A, Walker M, Helewa M, Dubé J, Tawagi G, Seaward G, Ohlsson A, Magee LA, Olatunbosun F, Gratton R, Shear R, Demianczuk N, Collet JP, Wei S, Fraser WD; INTAPP study group. Xu H, et al. Am J Obstet Gynecol. 2010 Mar;202(3):239.e1-239.e10. doi: 10.1016/j.ajog.2010.01.050. Am J Obstet Gynecol. 2010. PMID: 20207239 Clinical Trial.

6

Ethics review as a component of institutional approval for a multicentre continuous quality improvement project: the investigator's perspective.

Ezzat H, Ross S, von Dadelszen P, Morris T, Liston R, Magee LA; CPN Collaborative Group. Ezzat H, et al. BMC Health Serv Res. 2010 Jul 30;10:223. doi: 10.1186/1472-6963-10-223. BMC Health Serv Res. 2010. PMID: 20673343 Free PMC article.

7

Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model.

von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Côté AM, Douglas MJ, Gruslin A, Hutcheon JA, Joseph KS, Kyle PM, Lee T, Loughna P, Menzies JM, Merialdi M, Millman AL, Moore MP, Moutquin JM, Ouellet AB, Smith GN, Walker JJ, Walley KR, Walters BN, Widmer M, Lee SK, Russell JA, Magee LA; PIERS Study Group. von Dadelszen P, et al. Among authors: smith gn. Lancet. 2011 Jan 15;377(9761):219-27. doi: 10.1016/S0140-6736(10)61351-7. Epub 2010 Dec 23. Lancet. 2011. PMID: 21185591 Free article. Clinical Trial.

8

The Canadian Perinatal Network: a national network focused on threatened preterm birth at 22 to 28 weeks' gestation.

Magee LA, von Dadelszen P, Allen VM, Ansermino JM, Audibert F, Barrett J, Brant R, Bujold E, Crane JMG, Demianczuk N, Joseph KS, Lee SK, Piedboeuf B, Smith G, Synnes A, Walker M, Whittle W, Wood S, Lee T, Li J, Payne B, Liston RM; Canadian Perinatal Network Collaborative Group (Appendix 2). Magee LA, et al. J Obstet Gynaecol Can. 2011 Feb;33(2):111-120. doi: 10.1016/S1701-2163(16)34795-8. J Obstet Gynaecol Can. 2011. PMID: 21352628

9

PIERS proteinuria: relationship with adverse maternal and perinatal outcome.

Payne B, Magee LA, Côté AM, Hutcheon JA, Li J, Kyle PM, Menzies JM, Peter Moore M, Parker C, Pullar B, von Dadelszen P, Walters BN; PIERS Study Group (Appendix); von Dadelszen P, Magee LA, Douglas MJ, Walley KR, Russell JA, Lee SK, Gruslin A, Smith GN, Côté AM, Moutquin JM, Brown MA, Davis G, Walters BN, Sass N, Duan T, Zhou J, Mahajan S, Noovao A, McCowan LA, Kyle P, Moore MP, Bhutta SZ, Bhutta ZA, Hall, Steyn DW, Broughton Pipkin F, Loughna P, Robson S, de Swiet M, Walker JJ, Grobman WA, Lindheimer MD, Roberts JM, Mark Ansermino J, Benton S, Cundiff G, Hugo D, Joseph KS, Lalji S, Li J, Lott P, Ouellet AB, Shaw D, Keith Still D, Tawagi G, Wagner B, Biryabarema C, Mirembe F, Nakimuli A, Tsigas E, Merialdi M, Widmer M. Payne B, et al. Among authors: smith gn. J Obstet Gynaecol Can. 2011 Jun;33(6):588-597. doi: 10.1016/S1701-2163(16)34907-6. J Obstet Gynaecol Can. 2011. PMID: 21846448

10

Ten-year, thirty-year, and lifetime cardiovascular disease risk estimates following a pregnancy complicated by preeclampsia.

Smith GN, Pudwell J, Walker M, Wen SW. Smith GN, et al. J Obstet Gynaecol Can. 2012 Sep;34(9):830-835. doi: 10.1016/S1701-2163(16)35381-6. J Obstet Gynaecol Can. 2012. PMID: 22971451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

453 results

Search Page

Filters